Literature DB >> 22313956

Prevalent tuberculosis and mortality among HAART initiators.

Daniel Westreich1, Matthew P Fox, Annelies Van Rie, Mhairi Maskew.   

Abstract

The effect of tuberculosis on mortality in people initiating highly-active antiretroviral therapy (HAART) remains unclear; here, we strengthened a previous cohort analysis. Multivariate Cox proportional hazards models were used to assess the association of baseline tuberculosis and time to all-cause mortality among HAART initiators. In reanalysis, treatment for tuberculosis at time of HAART initiation remained unassociated with increased risks of all-cause mortality, with adjusted hazard ratios ranging from 1.00 to 1.09.

Entities:  

Mesh：

Year:  2012        PMID： 22313956      PMCID： PMC3348652          DOI： 10.1097/QAD.0b013e328351f6b8

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  15 in total

1.  Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.

Authors:  Fernando Dronda; Paz Sobrino; Beatriz Hernández-Novoa; Ana M Caro-Murillo; Marta Montero; José A Iribarren; Jesús Sanz; María Del Mar Alonso; Pablo Labarga; Enrique Bernal; Santiago Moreno
Journal:  Curr HIV Res       Date:  2011-06       Impact factor: 1.581

2.  Using causal diagrams to guide analysis in missing data problems.

Authors:  Rhian M Daniel; Michael G Kenward; Simon N Cousens; Bianca L De Stavola
Journal:  Stat Methods Med Res       Date:  2011-03-09       Impact factor: 3.021

3.  Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa.

Authors:  Matthew P Fox; Alana Brennan; Mhairi Maskew; Patrick MacPhail; Ian Sanne
Journal:  Trop Med Int Health       Date:  2010-02-17       Impact factor: 2.622

4.  Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Authors:  Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

5.  Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa.

Authors:  Elvin H Geng; Nneka Emenyonu; Mwebesa Bosco Bwana; David V Glidden; Jeffrey N Martin
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

6.  Effect of pulmonary tuberculosis on mortality in patients receiving HAART.

Authors:  Daniel Westreich; Patrick MacPhail; Annelies Van Rie; Babatyi Malope-Kgokong; Prudence Ive; Dennis Rubel; Ronan Boulmé; Joseph Eron; Ian Sanne
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

7.  The effect of tuberculosis on mortality in HIV positive people: a meta-analysis.

Authors:  Masja Straetemans; Ana L Bierrenbach; Nico Nagelkerke; Philippe Glaziou; Marieke J van der Werf
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

8.  Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Matthias Egger; Ben D Spycher; John Sidle; Ralf Weigel; Elvin H Geng; Matthew P Fox; Patrick MacPhail; Gilles van Cutsem; Eugène Messou; Robin Wood; Denis Nash; Margaret Pascoe; Diana Dickinson; Jean-François Etard; James A McIntyre; Martin W G Brinkhof
Journal:  PLoS Med       Date:  2011-01-18       Impact factor: 11.069

9.  Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study.

Authors:  Ian M Sanne; Daniel Westreich; Andrew P Macphail; Dennis Rubel; Pappie Majuba; Annelies Van Rie
Journal:  J Int AIDS Soc       Date:  2009-12-17       Impact factor: 5.396

Review 10.  Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox; Christopher J Gill
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069
View more
  5 in total

1.  Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators: accurate tuberculosis diagnosis is essential.

Authors:  Stephen D Lawn; Ankur Gupta; Robin Wood
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

Review 2.  Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.

Authors:  E L Corbett; P MacPherson
Journal:  Int J Tuberc Lung Dis       Date:  2013-09       Impact factor: 2.373

3.  Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.

Authors:  André R S Périssé; Laura Smeaton; Yun Chen; Alberto La Rosa; Ann Walawander; Apsara Nair; Beatriz Grinsztejn; Breno Santos; Cecilia Kanyama; James Hakim; Mulinda Nyirenda; Nagalingeswaran Kumarasamy; Umesh G Lalloo; Timothy Flanigan; Thomas B Campbell; Michael D Hughes
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

4.  Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy.

Authors:  Daniel Westreich; Mhairi Maskew; Denise Evans; Cindy Firnhaber; Pappie Majuba; Ian Sanne
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

Review 5.  The effect of tuberculosis treatment at combination antiretroviral therapy initiation on subsequent mortality: a systematic review and meta-analysis.

Authors:  Heidi M Soeters; Charles Poole; Monita R Patel; Annelies Van Rie
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.